Maher Masoud
President and CEO at MaxCyte Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: MaxCyte Inc., 2 years.
MaxCyte Inc.
Director · President and CEO
Chief executive roles
MaxCyte Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 27, 2026 | MaxCyte Inc. | Grant or award | +300,000 | — | — |
| Aug 13, 2025 | MaxCyte Inc. | Open-market purchase | +75,000 | $1.37 | $102,750 |
| Jun 10, 2024 | MaxCyte Inc. | Open-market purchase | +70,443 | $4.90 | $345,171 |
| Jun 7, 2024 | MaxCyte Inc. | Open-market purchase | +29,557 | $4.87 | $143,943 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.